GENITOURINARY SYNDROME OF MENOPAUSE (GSM)
Clinical trials for GENITOURINARY SYNDROME OF MENOPAUSE (GSM) explained in plain language.
Never miss a new study
Get alerted when new GENITOURINARY SYNDROME OF MENOPAUSE (GSM) trials appear
Sign up with your email to follow new studies for GENITOURINARY SYNDROME OF MENOPAUSE (GSM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Menopause symptom study pulled before enrolling a single patient
Symptom relief TerminatedThis study aimed to see if adding a hyaluronic acid-based vaginal moisturizer to standard vaginal estrogen therapy provides extra relief for menopause-related vaginal symptoms. It planned to enroll postmenopausal women aged 45 and older who had not used these treatments recently.…
Matched conditions: GENITOURINARY SYNDROME OF MENOPAUSE (GSM)
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Laser therapy offers hope for cancer survivors with menopause symptoms
Symptom relief OngoingThis study tests a non-hormonal laser treatment for genitourinary syndrome of menopause (GSM) in women who have completed cancer treatment. GSM causes symptoms like vaginal dryness and pain, which can affect quality of life. The study will compare the laser therapy to a control g…
Matched conditions: GENITOURINARY SYNDROME OF MENOPAUSE (GSM)
Phase: NA • Sponsor: Institute of Oncology Ljubljana • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC